Neonatal management of the very low birth weight infant: the use of surfactant.
The use of surfactant in the low birth weight infant with respiratory distress syndrome has undergone multicenter randomized clinical trials. This article addresses the properties of surfactant, the clinical aspects of surfactant replacement therapy and the implications for future research.
Martin
G I
GI
Department of Pediatrics and Neonatology, Queen of the Valley Hospital, Magan Medical Clinic, Covina, California.
Sindel
B D
BD
D055592:Biophysical Phenomena; D001703:Biophysics; D005260:Female; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007752:Obstetric Labor, Premature / Q000150:complications*; D011247:Pregnancy; D011663:Pulmonary Surfactants / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy* / Q000209:etiology
D011663:Pulmonary Surfactants